|
Index of reports
> Cases with Dyspnoea (65)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neulasta (Pegfilgrastim) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 65 Next >>
Possible Neulasta side effects in 62 year old female
Reported by a physician from Finland on 2012-08-27
Patient: 62 year old female
Reactions: Back Pain, Dysphagia, Stomatitis, Dyspnoea, Pain in Extremity, Hypotension, Bone Pain, Constipation, Abdominal Pain Upper, Joint Stiffness, Myalgia, Malaise, Insomnia, Oedema Peripheral, Musculoskeletal Stiffness, Gait Disturbance, Candidiasis
Drug(s) suspected as cause:
Docetaxel
Dosage: 80 mg/m2, unk
Indication: Metastasis
Start date: 2012-04-26
End date: 2012-04-28
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Start date: 2012-04-28
End date: 2012-06-11
Neupogen
Dosage: unk
Indication: Chemotherapy
Start date: 2012-07-21
End date: 2012-07-27
Possible Neulasta side effects in 50 year old female
Reported by a physician from United Kingdom on 2012-08-23
Patient: 50 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Swelling Face, Dyspnoea, Body Temperature Increased, Drug Ineffective, Neutropenic Sepsis, Anaphylactic Reaction, Swollen Tongue, Erythema, Oedema Mucosal, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Fluorouracil; Dexamethasone; Zofran; Metoclopramide; Epirubicin; Cyclophosphamide
Possible Neulasta side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-20
Patient: 77 year old female, weighing 85.0 kg (187.0 pounds)
Reactions: Myalgia, Dyspnoea, Malaise, Palpitations, Sepsis, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Docetaxel; Doxorubicin Hydrochloride
Possible Neulasta side effects in 62 year old female
Reported by a physician from Finland on 2012-08-01
Patient: 62 year old female
Reactions: Dysphagia, Stomatitis, Dyspnoea, Pain in Extremity, Bone Pain, Hypotension, Constipation, Myalgia, Malaise, Oedema Peripheral, Insomnia, Musculoskeletal Stiffness, Gait Disturbance, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: unk
Start date: 2012-05-19
Neulasta
Dosage: unk
Start date: 2012-05-21
Neupogen
Dosage: unk
Indication: Chemotherapy
Start date: 2012-07-21
Neulasta
Dosage: unk
Indication: Chemotherapy
Start date: 2012-04-28
End date: 2012-06-11
Neulasta
Dosage: unk
Start date: 2012-06-11
Other drugs received by patient: Docetaxel
Possible Neulasta side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from Slovenia on 2012-07-16
Patient: 51 year old female, weighing 85.0 kg (187.0 pounds)
Reactions: Emotional Distress, Dyspnoea, Nausea, Hypotension, Anaphylactic Shock, Hyperhidrosis, Oxygen Saturation Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Kytril; Medrol; Anthracyclines and Related Substances
Possible Neulasta side effects in 51 year old female
Reported by a physician from Slovenia on 2012-07-04
Patient: 51 year old female
Reactions: Emotional Distress, Dyspnoea, Nausea, Hypotension, Anaphylactic Shock, Hyperhidrosis, Oxygen Saturation Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Kytril; Medrol; Antineoplastic Agents
Possible Neulasta side effects in 50 year old female
Reported by a physician from United Kingdom on 2012-07-02
Patient: 50 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Swelling Face, Dyspnoea, Body Temperature Increased, Drug Ineffective, Anaphylactic Reaction, Neutropenic Sepsis, Swollen Tongue, Erythema, Oedema Mucosal, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Fluorouracil; Zofran; Metoclopramide; Epirubicin; Dexamethasone; Cyclophosphamide
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28
Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)
Reactions: Dyspnoea, Chest Discomfort, Fatigue, Chest Pain, Sensation of Pressure
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg milligram(s) subcutaneous
Indication: Chemotherapy
Ranitidine
Dosage: 50 mg milligram(s), intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
(Domperidone)
Dosage: 20 mg milligram(s), 1 day, oral ; 20 mg, as needed
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg milligram(s) oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg milligram(s), intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg milligram(s) intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: see image
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Paclitaxel
Dosage: see image
Indication: Breast Cancer
End date: 2011-07-05
Other drugs received by patient: (Docusate); (Biotene / 00203502 / )
Possible Neulasta side effects in 60 year old male
Reported by a physician from United States on 2012-06-26
Patient: 60 year old male
Reactions: Dyspnoea, Myelitis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Orthostatic Hypotension, Death, Neurotoxicity, Neoplasm Malignant, Adrenal Insufficiency, Brain Oedema, Carbon Dioxide Decreased, Graft Loss, Jugular Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: Product Used FOR Unknown Indication
Nplate
Dosage: unk
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2008-09-24
End date: 2008-12-07
Nplate
Dosage: unk
Aranesp
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2008-10-17
Nplate
Dosage: unk
Nplate
Dosage: unk
Nplate
Dosage: unk
Nplate
Dosage: unk
Start date: 2008-09-24
End date: 2008-12-07
Other drugs received by patient: Immunoglobulins; Naproxen; Prochlorperazine Maleate; Daunorubicin HCL; Dexamethasone; Multivitamin / 00097801 /; Fluticasone Propionate; Azithromycin; Alprazolam; Prednisone; Ondansetron (Zofran); Fludarabine Phosphate; Anti-Thymocyte Globulin NOS; Rituximab; Decadron; Tricor; Blood and Related Products; Prograf; Carboplatin; Ifex; Mesna; Methotrexate; Aloxi; Etoposide; Cytarabine; Potassium Chloride; Metformin HCL; Busulfan; Lipitor; Valtrex; Pentamidine Isethionate; Cellcept; Benadryl; Cisplatin; Mucinex; Detrol LA; Triamterene and Hydrochlorothiazid; Iviglob-EX
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Dyspnoea, Fatigue
Drug(s) suspected as cause:
Neulasta
Indication: Chemotherapy
Granisetron
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
End date: 2011-07-05
Ranitidine
Indication: Product Used FOR Unknown Indication
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Dexamethasone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Cyclophosphamide; Docusate; Doxorubicin HCL; Biotene
Possible Neulasta side effects in
Reported by a physician from Belgium on 2012-06-06
Patient:
Reactions: Dyspnoea, Leukocytosis
Drug(s) suspected as cause:
Neulasta
Possible Neulasta side effects in female
Reported by a physician from Denmark on 2012-06-06
Patient: female, weighing 74.0 kg (162.8 pounds)
Reactions: Back Pain, Dyspnoea, Neck Pain, Arthralgia, Pulmonary Embolism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Mabthera
Dosage: last dose prior to sae was on 13/feb/2012
Start date: 2012-03-05
Vincristine
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Prednisone
Dosage: last dose prior to sae was on 9/mar/2012
Administration route: Oral
Start date: 2012-03-05
Mabthera
Start date: 2012-02-13
Cyclophosphamide
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Doxorubicin Hydrochloride
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Doxorubicin Hydrochloride
Start date: 2012-03-05
Neulasta
Start date: 2012-02-23
Cyclophosphamide
Dosage: 05/mar/2012: last dose prioe to onset of sae
Start date: 2012-03-05
Prednisone
Administration route: Oral
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Prednisone
Administration route: Oral
Start date: 2012-02-20
End date: 2012-02-24
Neulasta
Start date: 2012-03-08
Vincristine
Start date: 2012-03-05
Prednisone
Administration route: Oral
Start date: 2012-02-27
End date: 2012-02-27
Neulasta
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-10
End date: 2012-02-10
Other drugs received by patient: Acyclovir; Lansoprazole; Ondansetron; Bactrim
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-01
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain
Adverse event resulted in: death
Drug(s) suspected as cause:
Ranitidine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: unk
Administration route: Oral
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Dexamethasone
Dosage: unk
Paclitaxel
Dosage: 300 mg, 1/2 weeks
End date: 2011-07-05
Neulasta
Indication: Chemotherapy
Dexamethasone
Dosage: unk
Indication: Product Used FOR Unknown Indication
Pegfilgrastim
Dosage: unk
Indication: Chemotherapy
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg, 1/2 weeks
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Other drugs received by patient: Docusate; Biotene DRY Mouth
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30
Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)
Reactions: Dyspnoea, Fatigue, Chest Discomfort, Hypopnoea, Chest Pain
Drug(s) suspected as cause:
Ranitidine
Dosage: 50 mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg milligram(s) (1 day), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
(Chlorphenamine)
Dosage: 10 mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg milligram(s), subcutaneous
Indication: Chemotherapy
Dexamethasone
Dosage: 20 mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-05
Paclitaxel
Dosage: 315 mg milligram(s) (2 week), intravenous
Indication: Breast Cancer
End date: 2011-07-05
Paclitaxel
Dosage: 315 mg milligram(s) (2 week), intravenous
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
(Domperidone)
Dosage: 20 mg milligram(s), 1 day, oral, 20 mg, as needed, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg milligram(s) (1 day), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: (Biotene); Docusate
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Fatigue, Dyspnoea, Chest Pain, Obstructive Airways Disorder, Sensation of Pressure
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk, sc
Indication: Chemotherapy
Dexamethasone
Dosage: 4 mg, bid, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone (Domperidone)
Dosage: 20 mg, unk, po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg, unk, iv
Indication: Product Used FOR Unknown Indication
Dexamethasone Sodium Phosphate
Dosage: 20 mg, unk, iv
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315;300 mg, unk, iv
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Paclitaxel
Dosage: 315;300 mg, unk, iv
Indication: Breast Cancer
Start date: 2011-06-21
End date: 2011-07-05
Ranitidine
Dosage: 50 mg, unk, iv
Other drugs received by patient: Biotene; Docusate
Possible Neulasta side effects in 48 year old female
Reported by a pharmacist from United Kingdom on 2012-05-29
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Paclitaxel
Dosage: 315 mg, q2wk
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Motilium
Dosage: 20 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 300 mg, q2wk
Start date: 2011-06-21
End date: 2011-07-05
Ranitidine
Dosage: 50 mg, unk
Indication: Product Used FOR Unknown Indication
Chlorpheniramine TAB
Dosage: 10 mg, unk
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Dexamethasone
Dosage: 20 mg, bid
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Docusate; Biotene / 06680101 /
Possible Neulasta side effects in 48 year old female
Reported by a physician from United Kingdom on 2012-05-23
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Chest Discomfort, Fatigue, Dyspnoea, Chest Pain
Drug(s) suspected as cause:
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Ranitidine
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 8mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Paclitaxel
Dosage: 300mg every two weeks
Start date: 2011-06-21
End date: 2011-07-05
Dexamethasone
Granisetron
Dosage: 2mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315mg every two weeks
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Neulasta
Indication: Chemotherapy
Other drugs received by patient: Biotene DRY Mouth Mouthwash; Docusate
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-22
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Depth Decreased, Dyspnoea, Chest Discomfort, Fatigue, Chest Pain
Drug(s) suspected as cause:
Chlorpheniramine TAB
Dosage: 10 mg, unk
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Paclitaxel
Dosage: 300 mg, q2wk
End date: 2011-07-05
Dexamethasone
Dosage: 20 mg, unk
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg, unk
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Dexamethasone
Dosage: 4 mg, unk
Administration route: Oral
Ranitidine
Dosage: 50 mg, unk
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Biotene / 06680101 /; Docusate
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-16
Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)
Reactions: Respiratory Depth Decreased, Product Substitution Issue, Dyspnoea, Fatigue, Chest Discomfort, Chest Pain, Obstructive Airways Disorder, Discomfort
Drug(s) suspected as cause:
Granisetron
Dosage: 1 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Domperidone
Dosage: 20 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine
Dosage: 50mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg milligram(s), subcutaneous
Indication: Chemotherapy
Chlorpheniramine TAB
Dosage: 10 mg (milligram(s), intravenous
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg milligram(s), intravenous
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Other drugs received by patient: Docusate; Biotene
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-14
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Chest Discomfort, Fatigue, Dyspnoea
Adverse event resulted in: death
Drug(s) suspected as cause:
Domperidone
Administration route: Oral
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Pegfilgrastim
Indication: Chemotherapy
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Domperidone
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: unk
Indication: Breast Cancer
Start date: 2011-06-21
End date: 2011-07-05
Paclitaxel
Dosage: unk
Start date: 2011-05-24
End date: 2011-07-05
Ranitidine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: unk
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg, bid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg every 2 weeks
Start date: 2011-05-24
End date: 2011-06-07
Neulasta
Indication: Chemotherapy
Other drugs received by patient: Docusate; Biotene DRY Mouth
Possible Neulasta side effects in 48 year old female
Reported by a physician from United States on 2012-05-11
Patient: 48 year old female
Reactions: LIP Swelling, Pruritus, Hypersensitivity, Dyspnoea, Tachycardia, Urticaria
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Toprol-XL; Diflucan; Taxotere; Cytoxan
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Dyspnoea, Fatigue, Chest Discomfort, Chest Pain
Drug(s) suspected as cause:
Domperidone (Domperidone)
Dosage: 20 mg;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg;iv ; 300 mg;iv
Indication: Breast Cancer
Start date: 2011-06-21
End date: 2011-07-05
Paclitaxel
Dosage: 315 mg;iv ; 300 mg;iv
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Dexamethasone Sodium Phosphate
Dosage: 20 mg;iv
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg;sc
Indication: Chemotherapy
Granisetron
Dosage: 1 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine
Dosage: 50 mg;iv
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg;iv
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Docusate; Biotene / 00203502 /
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Fatigue, Chest Discomfort, Dyspnoea
Drug(s) suspected as cause:
Neulasta
Indication: Chemotherapy
Chlorpheniramine TAB
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine
Indication: Product Used FOR Unknown Indication
Granisetron
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Other drugs received by patient: Doxorubicin HCL; Docusate; Cyclophosphamide; Biotene
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10
Patient: 48 year old female
Reactions: Chest Discomfort, Fatigue, Dyspnoea
Drug(s) suspected as cause:
Chlorpheniramine TAB
Dosage: 10 mg; ;iv
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg; sc
Indication: Chemotherapy
Dexamethasone Sodium Phosphate
Dosage: 20 mg; ;iv
Indication: Product Used FOR Unknown Indication
Domperidone (Domperidone)
Dosage: 20 mg; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ranitidine
Dosage: 50 mg; iv
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 315 mg; ;iv, 300 mg;iv
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Other drugs received by patient: Docusate; Biotene - / 00203502 /
Possible Neulasta side effects in female
Reported by a physician from United States on 2012-05-09
Patient: female
Reactions: Dyspnoea
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Antineoplastic Agents
Possible Neulasta side effects in female
Reported by a physician from United States on 2012-05-08
Patient: female
Reactions: Dyspnoea, Hypersensitivity, Breast Disorder, Chills, Bone Pain, Skin Disorder, Pyrexia, Erythema, Tremor, Dysstasia, Dehydration, Acute Respiratory Distress Syndrome, Asthenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Taxotere; Tylenol (Caplet); Zofran; Compazine; Cytoxan; Dexamethasone
Possible Neulasta side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Dyspnoea, Chest Discomfort, Fatigue
Drug(s) suspected as cause:
Domperidone
Dosage: 20 mg, unk
Administration route: Oral
Chlorpheniramine Maleate
Dosage: 10 mg, unk
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Granisetron
Dosage: 1 mg, unk
Administration route: Oral
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Ranitidine
Dosage: 50 mg, unk
Other drugs received by patient: Biotene; Docusate
Possible Neulasta side effects in 48 year old female
Reported by a pharmacist from United Kingdom on 2012-05-03
Patient: 48 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Fatigue, Dyspnoea, Chest Discomfort
Drug(s) suspected as cause:
Ranitidine
Indication: Product Used FOR Unknown Indication
Neulasta
Indication: Chemotherapy
Granisetron
Dosage: 2mg per day
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 8mg per day
Administration route: Oral
Domperidone
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Paclitaxel
Start date: 2011-06-21
End date: 2011-07-05
Chlorpheniramine Maleate
Indication: Product Used FOR Unknown Indication
Domperidone
Administration route: Oral
Dexamethasone
Indication: Product Used FOR Unknown Indication
Paclitaxel
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-06-07
Other drugs received by patient: Docusate; Biotene DRY Mouth Mouthwash
Possible Neulasta side effects in 42 year old female
Reported by a pharmacist from United Kingdom on 2012-05-03
Patient: 42 year old female
Reactions: Back Pain, Abdominal Pain, Dyspnoea, Chest Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Epirubicin; Palonosetron; Aprepitant; Cyclophosphamide; Fluorouracil
Possible Neulasta side effects in female
Reported by a physician from Denmark on 2012-04-30
Patient: female, weighing 74.0 kg (162.8 pounds)
Reactions: Back Pain, Dyspnoea, Neck Pain, Arthralgia, Pulmonary Embolism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Start date: 2012-02-13
Cyclophosphamide
Dosage: 05/mar/2012: last dose prioe to onset of sae
Start date: 2012-03-05
Prednisone TAB
Administration route: Oral
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Prednisone TAB
Dosage: last dose prior to sae was on 9/mar/2012
Administration route: Oral
Start date: 2012-03-05
Cyclophosphamide
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Doxorubicin HCL
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Mabthera
Dosage: last dose prior to sae was on 13/feb/2012
Start date: 2012-03-05
Vincristine
Start date: 2012-03-05
Vincristine
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Prednisone TAB
Administration route: Oral
Start date: 2012-02-27
End date: 2012-02-27
Doxorubicin HCL
Start date: 2012-03-05
Neulasta
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-10
End date: 2012-02-10
Neulasta
Start date: 2012-02-23
Mabthera
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-02-07
Prednisone TAB
Administration route: Oral
Start date: 2012-02-20
End date: 2012-02-24
Neulasta
Start date: 2012-03-08
Other drugs received by patient: Ondansetron; Bactrim; Acyclovir; Lansoprazole
Page 1 Next >>
|
